MENU
SAVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cassava Sciences (SAVA) Ownership - Who owns Cassava Sciences?

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease... Show more

Profile

Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
29
Web
https://www.cassavasciences.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.46M
P/E Ratio
N/A
Total Cash
128.57M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-1.31
Dividend Yield
N/A
Total Cash/Share
2.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SAVA
Capitalization
72.5M
P/E Ratio
N/A
Risk (Beta)
-1.31
Dividend Yield
N/A
Total Cash
129M
Total Cash/Share
2.66
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
146M
P/B Ratio
0.46
Cash Flow
N/A
Earnings
-0.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
48K
Current Ratio
11.62
Current Revenue Per Employee
4405500.00
Dividends Per Share - Security
N/A
EBITDA
-141.15M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-15.75
Shares Held By Institutions
104M
Shares Outstanding - Current
48.3M
Total Liabilities
11.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-41.525
View a ticker or compare two or three
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
29
Web
https://www.cassavasciences.com